Press release
Frataxin Mitochondrial (Friedreich Ataxia Protein or FXN or EC 1.16.3.1), H1, 2017, Market Pipeline Research Report
Market Research Hub
Request Free Sample Report @ http://www.marketresearchhub.com/enquiry.php?type=S&repid=1177489
Frataxin Mitochondrial (Friedreich Ataxia Protein or FXN or EC 1.16.3.1) - Frataxin is a protein encoded by the FXN gene. It promotes the biosynthesis of heme and assembly and repair of iron-sulfur clusters by delivering Fe2+ to proteins involved in these pathways. It plays a role in the protection against iron-catalyzed oxidative stress through its ability to catalyze the oxidation of Fe2+ to Fe3.
Frataxin Mitochondrial (Friedreich Ataxia Protein or FXN or EC 1.16.3.1) pipeline Target constitutes close to 10 molecules. Out of which approximately 8 molecules are developed by companies and remaining by the universities/institutes. The molecules developed by companies in Phase II, Preclinical and Discovery stages are 1, 5 and 2 respectively. Similarly, the universities portfolio in Discovery stages comprises 2 molecules, respectively. Report covers products from therapy areas Central Nervous System which include indications Friedreich Ataxia.
The report is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources.
Scope
- The report provides a snapshot of the global therapeutic landscape for Frataxin Mitochondrial (Friedreich Ataxia Protein or FXN or EC 1.16.3.1)
- The report reviews Frataxin Mitochondrial (Friedreich Ataxia Protein or FXN or EC 1.16.3.1) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved in Frataxin Mitochondrial (Friedreich Ataxia Protein or FXN or EC 1.16.3.1) targeted therapeutics and enlists all their major and minor projects
- The report assesses Frataxin Mitochondrial (Friedreich Ataxia Protein or FXN or EC 1.16.3.1) targeted therapeutics based on mechanism of action (MoA), route of administration (RoA) and molecule type
- The report summarizes all the dormant and discontinued pipeline projects
- The report reviews latest news and deals related to Frataxin Mitochondrial (Friedreich Ataxia Protein or FXN or EC 1.16.3.1) targeted therapeutics
Browse Full Report with TOC @ http://www.marketresearchhub.com/report/frataxin-mitochondrial-friedreich-ataxia-protein-or-fxn-or-ec-11631-pipeline-review-h1-2017-report.html
Reasons to buy:
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand the targeted therapy areas and indications for Frataxin Mitochondrial (Friedreich Ataxia Protein or FXN or EC 1.16.3.1)
- Identify the use of drugs for target identification and drug repurposing
- Identify potential new clients or partners in the target demographic
- Develop strategic initiatives by understanding the focus areas of leading companies
- Plan mergers and acquisitions effectively by identifying key players and its most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Frataxin Mitochondrial (Friedreich Ataxia Protein or FXN or EC 1.16.3.1) development landscape
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Make an Enquiry @ http://www.marketresearchhub.com/enquiry.php?type=enquiry&repid=1177489
About Market Research Hub:
Market Research Hub (MRH) is a next-generation reseller of Research Reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.
MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.
Contact Details:
90 State Street,
Albany, NY 12207,
United States
Toll Free: 866-997-4948 (US-Canada)
Tel: +1-518-621-2074
Email: press@marketresearchhub.com
Read More Industry News @ https://www.industrynewsanalysis.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Frataxin Mitochondrial (Friedreich Ataxia Protein or FXN or EC 1.16.3.1), H1, 2017, Market Pipeline Research Report here
News-ID: 597112 • Views: …
More Releases from Market Research Provider - MRH
Global Sports Accessories Market Status & Growth Analysis Forecasted till 2022
Market Research Hub (MRH) has included a new report titled “Global Sports Accessories Market Research Report 2017”, to its huge database. This research study includes information about the regional production along with revenue and market share. The report further updates that the sports market on the global level would acquire a rise at a positive CAGR during the period 2017-2022, which is surely a major boost for the concerned sector.…
Global Film Release Liners Market to Rise at an Impressive Rate during the Forec …
The demand for film release liners is greatly influenced by the advancements in the packaging industry. The increased preference for modern and latest packaging all across the world, coupled with the increasing investments in the pharmaceuticals and the food and beverages industries, is expected to drive the demand in the global market for film release liners over the coming years. A new market report with a title “Global Film Release…
Global Coated Graphite Market Status, Trends & Future Outlook until 2022
The latest research report added to the vast database of Market Research Hub (MRH). The study is titled “Global Coated Graphite Market Research Report 2017”, which includes information about the regional segmentation on the basis of factors such as production, consumption, revenue, and market share. It is also mentioned that the market would soon acquire growth at a double-digit CAGR between 2017 and 2022.
Request Free Sample Report @ http://www.marketresearchhub.com/enquiry.php?type=S&repid=1217172
Geographically, this…
More Releases for Frataxin
Friedreich Ataxia (FA): Emerging Therapies, Unmet Needs & TPP Insights Reshape P …
As the therapeutic landscape for Friedreich Ataxia evolves beyond symptomatic management, developers are increasingly focused on disease-modifying strategies, gene replacement, frataxin restoration, and mitochondrial-targeted therapies. Success in this rare neurodegenerative disorder will depend not only on clinical efficacy but also on aligning development programs with the unmet expectations of patients, clinicians, regulators, and payers.
Friedreich Ataxia: A Rare Disease Entering a New Phase of Therapeutic Innovation
Friedreich Ataxia (FA) is a rare,…
Friedreich's Ataxia Market Outlook & Forecast: A 10-Year Framework for the Evolv …
The Friedreich's Ataxia market is no longer a static rare disease space; it's a field in motion. With the first approved disease-specific therapy now anchoring the commercial landscape, and a wave of gene therapies, frataxin replacement strategies, and multi-mechanism pipeline assets gaining clinical momentum, this report arrives at a pivotal moment for anyone with commercial or scientific stakes in this indication.
Executive Summary
Friedreich's Ataxia is the most common inherited ataxia, affecting…
Frataxin Mitochondrial Market To Reach USD 682 Million By 2033 As Rare Disease T …
Global Frataxin Mitochondrial Market projected to grow at a CAGR of 17.2% through 2033, led by North America as gene therapies, mitochondrial medicine research, and precision diagnostics accelerate commercialization opportunities.
Market Overview
The global Frataxin Mitochondrial Market was valued at approximately USD 187 million in 2025 and is projected to reach USD 682 million by 2033, expanding at a CAGR of 17.2% between 2026 and 2033. The market is gaining momentum as…
Friedreich's Ataxia Pipeline Enters a Transformative Era with 20+ Therapies and …
The Friedreich's ataxia therapeutic landscape is undergoing a significant transformation, driven by robust clinical innovation and increasing research focus from leading biopharmaceutical companies.
Key Friedreich's Ataxia Companies such as Larimar Therapeutics, Minoryx Therapeutics, Design Therapeutics, Solid Biosciences, Alterity Therapeutics, Voyager Therapeutics, Capsida Biotherapeutics, Lexeo Therapeutics, and Papillon Therapeutics are actively advancing novel treatment strategies aimed at addressing the underlying genetic and mitochondrial dysfunctions associated with the disease. With over 20 pipeline…
United States Friedreich's Ataxia (FA) Market Growth (2025-2033): Emerging Thera …
DataM Intelligence has published a new research report on "Friedreich's Ataxia Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.
✅ North America is projected to maintain a…
Friedreich's Ataxia Treatment Market Size in the 7MM will experience significant …
Friedreich's Ataxia Treatment Market is projected to witness substantial growth over the next few years, driven by advancements in treatment modalities and increasing awareness of the condition. The pipeline for Friedreich's Ataxia Therapeutics includes promising candidates that aim to not only treat acute attacks but also prevent recurrence.
DelveInsight's "Friedreich's Ataxia Market Insights, Epidemiology and Market Forecast - 2034" report delivers an in-depth understanding of the Friedreich's Ataxia, historical and…
